Index

nutrition support, 251–264. See also enteral nutrition; parenteral nutrition

obesity, 10, 77 sarcopenic, 107–108

OBRA. See Omnibus Budget Reconciliation Act (OBRA)

occlusion, 137, 139, 258, 262 odynophagia, 156 OGTT. See oral glucose tolerance test (OGTT) Older Americans Act Nutrition Program (OAANP), 20, 73, 76 Oley Foundation, 263

olfactory perception, 8, 42, 84–85 omeprazole, 7, 167, 236 Omnibus Budget Reconciliation Act (OBRA), 30, 301, 307, 322, 348

Oncology Nutrition Evidence-Based Nutrition Practice Guildelines, 186 oral cancer, 5, 138, 190 oral cavity, 109, 134–141, 145, 190, 194 oral function risk factors, 136

oral glucose tolerance test (OGTT), 177, 221 Oral Health in America, 137 oral health problems, 136. See also dentition diet management guidelines for, 140 medical and physical risk factors, 137 nutritional risk questions, 135–136 oral health status, 137 oral mucositis, 196

oral nutrition intake, 74–75. See also hydration; food intake

oral nutrition management, 137 oral nutrition risk assessment, 138 orexigenic drugs (appetite stimulants), 109, 112–113

organ function, 74

oropharyngeal dysphagia, 148, 149, 150, 156 oropharynx, 5, 143, 190 osmolality, serum, 83, 127, 181, 224–225, 226 osteoarthritis, 41

osteoporosis, 78, 134, 136

outcomes management systems, 51–52 outpatient clinics, 27 over-the-counter drugs, 11, 82, 110, 233 oxandrolone, 121 oxidase inhibitors, 137

PAB. See prealbumin (PAB)

PAL. See physical activity levels (PAL) palliative care, 269–278 clinical issues, 271

ethical and legal issues, 275 physiological intake issues, 271 psychological issues, 271 social issues, 271

pancreas, 5, 184, 190, 194 paranoia, 42, 86 paraplegics, 81, 84

parathyroid hormone (PTH), 10, 171 parenteral nutrition (PN), 192, 235, 255, 260 complications of, 263 components of, 261–262 formula selection for, 257 indications for, 260 intravenous access, 261 monitoring, 262–263 prescription, 266–267

Parkinson’s disease, 39, 41, 85, 148, 155, 156, 234, 255

paroxetine, 121

patient-centered medical home, 26 Patient Protection and Affordable Care Act (ACA), 23–24, 285, 286, 326, 327 Paxil. See paroxetine PEG. See percutaneous endoscopic gastrostomy (PEG) PEM. See protein-energy malnutrition (PEM) Pepcid, 246

percutaneous endoscopic gastrostomy (PEG), 256 performance improvement (PI), 326–332, 334 See also Quality Assurance and Performance Improvement (QAPI)

performance improvement project (PIP), 326– 327, 332, 334, 335–336 perfusion, 199, 237 periactin, 121

periodontal disease, 4, 5, 135

peripherally inserted central catheter (PICC), 261 peripheral neuropathy, 77, 100, 233 peripheral parenteral nutrition (PPN), 261 peripheral vascular disease, 167 peritoneal dialysis, 171, 172, 173, 175 pernicious anemia, 83, 161, 163–164, 221, 222, 223, 224, 228, 229 PES (problem, etiology, signs and symptoms), 51, 54, 110, 113

pharmacogenomics, 239–240

395